Search results
Results From The WOW.Com Content Network
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious ...
[2] [3] Memoli participated in an ethics debate on vaccine mandates hosted by the NIH in December 2021. [2] On January 22, 2025, Memoli was appointed acting director of the NIH by the Trump administration. [3] [4] During his direction in early 2025, the NIH suffered from confusion regarding details of purchasing and conducting research. [5]
Additionally, NIAID partnerships with industry and academia have led to the advancement of diagnostic tests for several important infectious diseases, including malaria (ParaSight F), tuberculosis (GeneXpert MTB/RIF), and norovirus (Ridascreen Norovirus 3rd Generation EIA). NIAID has done research on mother-to-child transmission (MTCT) of HIV.
The National Institutes of Health, Islamabad (NIH) (Urdu: قومی ادارہَ صحت), is a Pakistani research institute located in Islamabad, Pakistan.. The institute is an autonomous body of Ministry of National Health Services, Regulation and Coordination, mainly responsible for biomedical and health related research along with vaccine manufacturing.
He was the director of the Vaccine Research Center [1] (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ...
The Division of Acquired Immunodeficiency Syndrome (DAIDS) is a division of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health. It was formed in 1986 as a part of the initiative to address the national research needs created by the advent and spread of the HIV/AIDS epidemic. [1]
She joined Harvard following six years at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. [3] [4] She earned a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill (UNC-Chapel Hill) in 2014. [5]
McLellan, along with Barney S. Graham and Peter Kwong of the National Institute of Allergy and Infectious Diseases' Vaccine Research Center, spearheaded the development of a protein subunit vaccine against RSV called DS-Cav1. [33] When the work began, McLellan was a postdoctoral researcher at VRC working in Graham's and Kwong's labs.